Risk factor reduction in progression of angiographic coronary artery disease

Archives of Medical Science

Volumn 8, Issue 3, 2012, Pages 444-448

  Lai, Hoang M ^a   Aronow, Wilbert S ^a   Mercando, Anthony D ^b   Kalen, Phoenix ^a   Desai, Harit V ^a   Gandhi, Kaushang ^a   Sharma, Mala ^a   Amin, Harshad ^a   Lai, Trung M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Blood pressure; Cholesterol; Coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTPATIENT; RISK REDUCTION; TREATMENT DURATION;

EID: 84863954580     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.29399     Document Type: Article

References (24)

1. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993; 87: 1067-75. (Pubitemid 23110377)
2. Mack WJ, Xiang M, Selzer RH, Hodis HN. Serial quantitative coronary angiography and coronary events. Am Heart J 2000; 139: 993-9. (Pubitemid 30390327)
3. Vigen C, Hodis HN, Selzer RH, et al. Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study). Am J Cardiol 2005; 95: 1277-82. (Pubitemid 40719856)
4. Alderman EL, Corley SD, Fisher LD, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol 1993; 22: 1141-54. (Pubitemid 23285768)
5. Daida H, Ouchi Y, Saito Y, et al. Preventing angiographic progression of coronary atherosclerosis with pravastatin. J Atheroscler Thromb 2003; 10: 25-31.
6. Yokoi H, Nobuyoshi M, Mitsudo K, et al. Three-year follow-up results of Angiographic Intervention Trial Using an HMG-CoA Reductase Inhibitor to Evaluate Retardation of Obstructive Multiple Atheroma (ATHEROMA) Study. Circ J 2005; 69: 875-83. (Pubitemid 41124252)
7. Ballantyne CM, Raichlen JS, Nicholls SJ, et al. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography. A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden. Circulation 2008; 117: 2458-66. (Pubitemid 351670452)
8. Sipahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006; 48: 833-8. (Pubitemid 44175741)
9. Borges JC, Lopes N, Soares PR, et al. Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery. J Cardiothorac Surg 2010; 5: 91.
10. Rodriguez-Granillo GA, Vos J, Bruining N, et al. Am J Cardiol 2007; 100: 159-63.
11. Mercando AD, Lai HM, Aronow WS, et al. Reduction in atherosclerotic events through use of aggressive risk factor reduction medications: a retrospective study in an outpatient cardiology practice. Arch Med Sci 2012; 8: 57-62.
12. Lai HM, Aronow WS, Rachdev A, et al. Incidence of mortality in 1,040 patients with coronary heart disease or hypertensive heart disease with normal and abnormal left ventricular ejection fraction and with normal and abnormal QRS duration. Arch Med Sci 2008; 4: 140-2.
13. Ramdeen N, Aronow WS, Chugh S, Asija A. Patients undergoing coronary angiography because of chest pain with hepatitis C virus have a higher prevalence of obstructive coronary artery disease than a control group. Arch Med Sci 2008; 4: 452-4.
14. Kannam H, Aronow WS, Chilappa K, et al. Association of the QRS duration on the resting electrocardiogram with the severity of coronary artery disease in 2,196 patients undergoing coronary angiography for suspected coronary artery disease. Arch Med Sci 2009; 5: 163-5.
15. 2 determined by intravascular ultrasound in patients with coronary artery calcium scores of 0-100, 100-200, 200-300, 300-400, and <400 determined by cardiac computer tomography. Arch Med Sci 2009; 5: 172-4.
16. Shen X, Aronow WS, Nair CK, et al. Thoracic aortic atheroma severity predicts high-risk coronary anatomy in patients undergoing transesophageal echocardiography. Arch Med Sci 2011; 7: 61-6.
17. Aronow WS. Osteoporosis, osteopenia, and atherosclerotic vascular disease. Arch Med Sci 2011; 7: 21-6.
18. Duncan KA, Sukhija R, Aronow WS, et al. Systolic compression of left main coronary artery by left ventricular pseudoaneurysm complicated by critical stenosis. Arch Med Sci 2012 (in press).
19. Lai HM, Aronow WS, Mercando AD, et al. The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice. Med Sci Monit 2011; 17: CR683-6.
20. Nicholls SJ, Wolski K, Sipahi I, et al. Rate of progression of coronary atherosclerotic plaque in women. J Am Coll Cardiol 2007; 49: 1546-51. (Pubitemid 46517965)
21. Zhao XQ, Kosinski AS, Barnhart HX, et al. Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery trial. Med Sci Monit 2003; 9: CR48-54. (Pubitemid 36330358)
22. Mancini GBJ, Hartigan PM, Bates ER, et al. Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy. Observations from the COURAGE trial. Circulation: Cardiovasc Interven 2011; 4: 545-52.
23. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society for Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011; 57: 2037-114.
24. Grundy SM, Cleeman JL, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-32.